14May
Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By:
Goodwin
Related
This white paper analyzes the interplay of those middle market health care business mergers and acqu...
Read More >
The Department of Treasury’s office that administers reviews of foreign investments in U.S. compani...
Read More >
The Setting Every Community Up for Retirement Enhancement Act of 2019 (“SECURE Act”), the sweeping...
Read More >
While world governments scramble to contain the spread of the coronavirus, businesses are fielding q...
Read More >
As in implementing regulation of Law of the Republic Indonesia No.5 of 1999 on the Prohibition of Mo...
Read More >
Seyfarth Synopsis: In a long-awaited decision with significant impact for the private equity industr...
Read More >